Published in PLoS Pathog on July 01, 2016
Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science (2005) 16.84
miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res (2013) 13.41
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab (2006) 12.41
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia (2007) 10.74
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev (2007) 10.15
Treatment of HCV infection by targeting microRNA. N Engl J Med (2013) 9.91
The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res (2012) 9.02
Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell (2008) 8.32
miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol (2004) 6.44
Rfam 11.0: 10 years of RNA families. Nucleic Acids Res (2012) 6.14
GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Res (2008) 6.07
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med (1998) 4.48
Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol (2001) 4.44
Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol (2009) 4.41
MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology (2009) 4.36
microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J (2008) 4.24
A regulatory cytoplasmic poly(A) polymerase in Caenorhabditis elegans. Nature (2002) 3.90
Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev (2009) 3.62
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene (2009) 3.51
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest (2012) 3.46
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A (2003) 3.38
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest (2012) 3.14
Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation. Cell (2004) 3.10
miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep (2009) 3.03
Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology (2010) 2.64
Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat Cell Biol (2009) 2.63
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res (2011) 2.34
Structural determinants that target the hepatitis C virus core protein to lipid droplets. J Biol Chem (2006) 2.18
Hepatitis C virus RNA functionally sequesters miR-122. Cell (2015) 2.04
Regulation of hepatic innate immunity by hepatitis C virus. Nat Med (2013) 1.93
Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology (1996) 1.80
Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest (2010) 1.61
Emerging role of microRNAs in liver diseases. World J Gastroenterol (2009) 1.45
Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. J Virol (2005) 1.23
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses (2013) 1.12
Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2. Cell Host Microbe (2014) 1.08
Specific miRNA stabilization by Gld2-catalyzed monoadenylation. Cell Rep (2012) 1.08
Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation. J Biol Chem (2004) 1.03
miR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation. Cell Host Microbe (2015) 1.01
The DNA/RNA-binding protein, translin, binds microRNA122a and increases its in vivo stability. J Androl (2008) 0.98
Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol (2014) 0.96
Inhibition of host translation by virus infection in vivo. Proc Natl Acad Sci U S A (2010) 0.93
The role of microRNAs in hepatitis C virus RNA replication. Arch Virol (2013) 0.91
A feedback loop consisting of microRNA 23a/27a and the β-like globin suppressors KLF3 and SP1 regulates globin gene expression. Mol Cell Biol (2013) 0.90
Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication. J Virol (2015) 0.86
Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein. Proteomics (2005) 0.84
Dual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses. PLoS Pathog (2015) 0.84
Interaction of hepatitis C virus core protein with Hsp60 triggers the production of reactive oxygen species and enhances TNF-alpha-mediated apoptosis. Cancer Lett (2009) 0.84
Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication. Antiviral Res (2011) 0.84
Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation. Biochem Biophys Res Commun (2012) 0.83
Regulation of hepatitis C virus replication by the core protein through its interaction with viral RNA polymerase. Biochem Biophys Res Commun (2009) 0.83
Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated Effect. PLoS Pathog (2015) 0.82
Poly(A) polymerase (PAP) diversity in gene expression--star-PAP vs canonical PAP. FEBS Lett (2014) 0.81
Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog (2014) 0.80
Structural basis for the activation of the C. elegans noncanonical cytoplasmic poly(A)-polymerase GLD-2 by GLD-3. Proc Natl Acad Sci U S A (2015) 0.80
Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot. PLoS One (2016) 0.78
Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway. J Antimicrob Chemother (2011) 0.78
RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein. Analyst (2009) 0.78
The antiviral activity of poly-γ-glutamic acid, a polypeptide secreted by Bacillus sp., through induction of CD14-dependent type I interferon responses. Biomaterials (2013) 0.77
Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells. Liver Int (2015) 1.43
Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase. Br J Pharmacol (2015) 0.78
Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2. Nanomedicine (2016) 0.76
DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses. Clin Exp Vaccine Res (2014) 0.75
T cell immunosenescence, hypertension, and arterial stiffness. Epidemiol Health (2014) 0.75
Clinical Factors and Viral Load Influencing Severity of Acute Hepatitis A. PLoS One (2015) 0.75
Prolonged silencing of diacylglycerol acyltransferase-1 induces a dedifferentiated phenotype in human liver cells. J Cell Mol Med (2015) 0.75